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Abstract
Objective: The objective of the following study is to determine the incidence of retinal vein occlusion (RVO) and identify 
the risk factors in RVO in patients presenting to a tertiary hospital in Rivers State.
Materials and Methods: The medical records of consecutive patients with RVO who presented to the retina clinic of 
the eye Department of University of Port Harcourt Teaching Hospital over a 5 year period were retrieved. Information 
extracted from the data included the demographic data of patients, presenting visual acuity, history of systemic and ocular 
disease, blood pressure and intraocular pressure. Data was analyzed using the Statistical Package for Social Sciences 
20.0. (IBM Corporation and its licensors 1989,2011).
Results: Out of the 364 patients seen at the retina clinic during this period, 27 (7.4%) had RVO. Seven patients had bilateral 
disease. The incidence of RVO in the retinal clinic was 7.4%. Systemic hypertension, diabetes mellitus, hyperlipidemia and 
glaucoma were the main risk factors recorded in our patients. Central retinal vein occlusion (CRVO) 20 (74%) was more 
predominant than branch retinal vein occlusion (BRVO) 7 (26%). 21 eyes of patients with CRVO had visual acuities of < 3/60, 
while 7 eyes of patients with BRVO had visual acuities less than 3/60. Vitreous hemorrhage 10 (52.6%) was the most common 
complication encountered. All cases of non‑perfused vein occlusion 4 (14.8%) were seen in patients who had CRVO.
Conclusion: The incidence of RVO in our hospital is high. RVO is a significant cause of visual impairment, with CRVO 
being more common. Identifying associated risk factors and treating these could help reduce the incidence of RVO.
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Introduction
Retinal vein occlusion (RVO) is a common vascular disorder 
of the retina. It causes marked or total visual loss in the 
middle aged or elderly, however no age group is immune.[1,2] 
It is the second most common retinal vascular disease 
after diabetic retinopathy.[1‑3] The prevalence of RVO 
has been shown to vary from 0.7% to 1.6% and it affects 
approximately 16 million people worldwide.[3,4]
The exact pathological event that occurs in RVO is unclear, 
but it is believed to result from intraluminal thrombus 
formation associated with changes in the blood constituents, 
blood flow or vessel wall consistent with Virchow’s triad for 
thrombogenesis.[5,6] Thrombotic occlusion of the central 
retinal vein can occur from various pathological events 
such as compression of the vein (mechanical pressure 
due to structural changes in the lamina cribosa including 
glaucomatous cupping, orbital disorders, inflammatory 
swelling in the optic nerve,) hemodynamic disturbances 
(associated with sluggish circulation), vessel wall changes 
such as vasculitis and changes in the blood (such as 
deficiency of thrombolytic factors).[5‑7]
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RVO has been shown to occur concomittantly with certain 
systemic disorders. These systemic disorders and certain ocular 
disorders are regarded as risk factors associated with RVO. 
These include; cardiovascular disease, hypertension, diabetes 
mellitus, hyperlipidemia, glaucoma and hyperopia.[8‑10]
RVO is classified according to the location of the obstruction 
into central retinal vein occlusion (CRVO) when the 
obstruction is at the optic nerve head, branch retinal vein 
occlusion (BRVO) when the obstruction involves a branch 
of the retinal vein and hemi retinal vein occlusion when one 
half of the retina supplied the vein is affected.
RVO is one of the most common retinal pathologies seen 
in the retinal unit of the eye Department of University of 
Port Harcourt Teaching hospital since its establishment 
about 7 years ago. Some of these patients present with 
complications and ocular morbidity is high. These patients 
also have been found to have systemic and ocular conditions 
which are associated with RVO.
This study is therefore aimed at determining the incidence 
of RVO and identifying the risk factors for this condition.
Materials and Methods
The medical records of all consecutive new patients who 
presented to the retina clinic of the eye department of 
University of Port Harcourt Teaching Hospital between 
January 2008 and December 2012 were extracted.
Parameters evaluated included patients demographic data, 
clinical diagnosis, type of RVO, ocular and systemic risk 
factors and ocular complications. CRVO was characterized 
by widespread scattered superficial and deep retinal 
hemorrhages with or without optic disc hyperemia, retinal 
edema, venous dilatation and sheathed veins. Old resolved 
CRVO was diagnosed by collateral vessels. BRVO was 
characterized by retinal hemorrhages within the sector of 
the retina supplied by the occluded vein. The presence of 
relative afferent pupilary defect was used to differentiate 
patients with ischemic and non‑ischemic CRVO. Fundal 
examinations were carried out with 90D stereoscopic 
lens and a mydriatic fundus camera. Optical coherence 
tomography was used to confirm macular edema (MO) 
and abnormally thickened retina. Other investigations 
carried out were; full blood counts, fasting blood sugar, 
glycosylated hemoglobin, lipid profile and urea, electrolyte 
and creatinine.
•	 Hypertension was defined as patients with blood 
pressure (BP) >140/90 mmHg, measured on 2 or more 
visits, seating
•	 Diabetes mellitus was defined as a fasting blood 
sugar >7.0 mmol/l
•	 Hyperlipidemia was defined as total cholesterol 
>7 mmol/l
•	 Patients who had glaucoma, had the primary open angle 
type
•	 Blindness was defined as visual acuity <3/60, 
while acuity of <6/18‑3/60 was regarded as visual 
impairment.
Information from each subject was entered into a Spread 
sheet using the Statistical Package for Social Sciences 
20.0 (IBM Corporation and its licensors 1989,2011) for 
Windows statistical software and analyzed. Comparison of 
variables was carried out using appropriate statistical tests. 
P < 0.05 were considered to be statistically significant.
Results
Out of the 364 patients seen in the retinal clinic over the 
5 year period, there were 27 new cases of RVO. The total 
population of patients seen in the entire eye clinic during 
the period under review was 24,363. There were 7 cases of 
bilateral involvement resulting in 34 eyes with RVO.
There were 7 males (26%) and 20 females (74%), giving 
a male to female ratio of 1:2.8. The ages ranged from 38 to 
73 years with a mean age 54.8 ± 10.1 years [Table 1].
Table 2 shows the association between RVO and glaucoma. 9 
(33.3%) patients with CRVO had glaucoma while 2 (7.4%) 
with BRVO had glaucoma. The difference was not statistically 
significant (df = 1 Fisher exact = 0.05). Table 3 shows 
the relationship between RVO and hypertension. 6 (22.2%) 
of patients with CRVO were hypertensive, whereas 3 of 
patients with BRVO were hypertensive. This was however not 
statistically significant (df = 1 Fisher exact P = 0.287). The 
relationship between RVO and diabetes mellitus is illustrated 
in Table 4. Diabetes mellitus was present in 10 (37.0%) 




Male Female Total 
20‑30 ‑ 1 1 (4)
31‑40 ‑ 1 1 (4)
41‑50 1 8 9 (33)
51‑60 5 4 9 (33)
61‑70 ‑ 5 5 (19)
71‑80 1 1 2 (7)
Total 7 20 27 (100)





BRVO 5 (18.5) 2 (7.4) 7 (25.9)
CRVO 11 (40.7) 9 (33.3) 20 (74.1)
Total 16 (59.3) 11 (40.7) 27 (100.0)
df=1, Fisher exact P=0.05. BRVO=Branch vein occlusion, CRVO=Central 
retinal vein occlusion, RVO=Retinal vein occlusion
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A fundus picture of a patient with retinal vein occlusion is 
shown in Figure 1.
Discussion
The incidence of RVO in this study was 7.4%. A study 
carried out in Onitsha reported a low incidence however 
the value were not recorded.[11] Studies carried out in the 
western world are mainly prevalence studies done with 
larger populations and it is therefore difficult to compare 
with our study.[3,12,13] A population based study will be 
required to determine the incidence or prevalence of RVO 
in our population as hospital based studies are never truly 
representative of the population.
RVO is a disease of the older population (age >50 years old). 
The mean age in this series was 54.8 ± 10.1 years.[3,13‑15] As 
you can see in Table 1, similar findings were reported in 
Onitsha.[11] There was a female preponderance in this 
study. This trend was also reported in the Onitsha study. 
This could be due to the fact that women in this area 
tend to take their health challenges more seriously and 
therefore present to the clinic more than men. The role of 
oral contraceptives may also play a significant role here as 
they have been implicated in vein occlusion.[16] These oral 
contraceptives and hormone replacement therapy are used 
more in women than men. Most other studies reported no 





CRVO 1 5 21 27
BRVO 2 2 3 7
Total 3 7 24 34
BCVA=Best corrected visual acuity, BRVO=Branch vein occlusion, 
CRVO=Central retinal vein occlusion




VH MO INV DNV
CRVO 10 5 1 2 18
BRVO ‑ ‑ 1 ‑ 1
Total 10 5 2 2 19
BRVO=Branch vein occlusion, CRVO=Central retinal vein occlusion, 
VH=Vitreous hemorrhage, MO=Macular edema, INV=Iris 
neovascularization, DNV=Disc neovascuarization
Table 8: Proportion of perfused and non‑perfused RVO
RVO Clincal type (frequency) (%) Total 
frequency (%)ISCH NISCH
CRVO 4 (14.8) 16 (59.3) 20 (74.1)
BRVO 0 (0.0) 7 (25.9) 7 (25.9)
Total 4 (14.8) 23 (85.2) 27 (100)
RVO=Retinal vein occlusion, ISCH=Ischemic retinal vein occlusion, 
NISCH=Non‑ischemic retinal vein occlusion, BRVO=Branch vein occlusion, 
CRVO=Central retinal vein occlusion





BRVO 4 (14.8) 3 (11.1) 7 (25.9)
CRVO 14 (51.9) 6 (22.2) 20 (74.1)
Total 18 (66.7) 9 (33.3) 27 (100.0)
df=1, Fisher exact P=0.287. BRVO=Branch vein occlusion, CRVO=Central 
retinal vein occlusion, RVO=Retinal vein occlusion
Table 4: Association between RVO and diabetes mellitus
Type of 
occlusion
Diabetes mellitus (n (%))
Absent Present Total
BRVO 5 (18.5) 2 (7.4) 7 (25.9)
CRVO 10 (37.0) 10 (37.0) 20 (74.1)
Total 15 (55.6) 12 (44.4) 27 (100.0)
χ2=3.18, df=1, P=0.075. BRVO=Branch vein occlusion, CRVO=Central 
retinal vein occlusion, RVO=Retinal vein occlusion





BRVO 0 (0.0) 1 (20.0) 1 (20.0)
CRVO 0 (0.0) 4 (80.0) 4 (80.0)
Total 0 (0.0) 5 (100.0) 5 (100.0)
df=1, Fisher exact, P=0.145. BRVO=Branch vein occlusion, CRVO=Central 
retinal vein occlusion, RVO=Retinal vein occlusion
patients who presented with CRVO while 2 (7.4%) patients 
with BRVO presented with diabetes mellitus. The difference 
was not statistically significant (Chi‑square = 3.18 
df = 1; P = 0.075). The relationship between RVO and 
hyperlipidemia was not statistically significant as shown in 
Table 5 (df = 1 Fisher exact P = 0.145). Only 4 (80%) 
patients with CRVO had hyperlipidemia while 1 (20%) 
patient with BRVO had hyperlipidemia.
20 patients (74%) had CRVO and 7 patients (26%) 
had BRVO. All cases of bilateral involvement were due to 
CRVO. 27 eyes (79.4%) had CRVO.
Table 6 shows that 21 eyes of patients with CRVO had 
presenting best corrected visual acuity of less than 3/60, 
while only 3 out of the seven eyes with BRVO had visual 
acuity of less than 3/60.
The ocular complications seen in this study were; vitreous 
hemorrhage (VH), MO, iris neovascularization and disc 
neovascularization. Ocular complications were seen in 
19 (70.4%) of the 27 cases. The complications were more 
in patients who had CRVO (94.7%) and VH (52.6%) was 
the most common complication seen [Table 7].
Four (14.8%) patients with CRVO had an ischemic vein 
occlusion while 16 (59.3%) had the non‑ischemic type 
[Table 8].
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significant gender difference while others reported a slight 
male preponderance.[12‑14]
Certain systemic diseases such as diabetes, hypertension 
and hyperlipidemia are associated with increasing age. This 
puts the patients at risk of end organ complications such as 
ocular complications. Studies have shown that advancing 
age, elevated BP, hyperlipidemia, elevated blood sugar 
and ocular perfusion were principal variables predicting 
incident RVO.[11,14,17] Systemic hypertension, diabetes and 
hyperlipidemia were the three systemic factors recorded in 
this study while glaucoma was the only ocular risk factor 
recorded. However, these were not statistically proven in 
our study to be significant. Further studies are necessary in 
a larger population to prove these associations. The Onitsha 
study recorded similar findings where systemic hypertension, 
diabetes and glaucoma were seen in their series.[11]
Most of the patients in this study presented with CRVO 
(27 eyes). BRVO was seen in only 7 eyes. This is supported 
by the Onitsha report where 83.7% of the patients had 
CRVO. However the opposite is reported from studies 
in the western world, where branch retinal vein is found 
to have a higher incidence than CRVO.[3,14,17] BRVO is 
thought to occur largely as a result of artherosclerosis. 
Patients in the developed countries tend to be more prone 
to artherosclerosis because of their type of diet compared 
with those in the developing countries. However with the 
trend increasing toward western diet and the increasing 
prevalence of diabetes and other disease related to 
artherosclerosis one may begin to see more cases of BRVO. 
All patients who had bilateral involvement where those 
with CRVO. This pattern was again reported in the Onitsha 
study where out of the 5 patients with bilateral disease, 4 
had CRVO. This pattern may be as a result of the fact that 
CRVO is predominant in the study population.
Patients with CRVO were found to have more profound 
visual loss than patients with BRVO. This can be explained 
from the pattern of affectation of the retina by the vessel 
involved. Central retinal artery usually involves the four 
quadrants and inadvertently the posterior pole is affected, 
compared with when only a branch is involved which may 
likely spare the macular.
The most common ocular complication causing impaired 
vision in this series was VH, followed by macula edema 
and these were all seen in cases with CRVO. Based on the 
clinical findings using pupillary light response, 4 patients 
in this study were classified as having the ischemic form 
of RVO, the rest were believed to be perfused, all the four 
cases occurred in patients with CRVO. However we were 
limited by the lack of facilities for fluorscein angiography 
to ascertain this.
The retrospective nature of the study was also a limitation 
as we were compelled to use what information was available 
in the records.
Conclusion
The incidence of RVO in our hospital is high. RVO is a 
significant cause of visual impairment, with CRVO being 
commoner. Women are more predisposed to the disease than 
men. Identifying associated risk factors and treating these 
could help reduce the incidence of RVO.
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